Every story in this section, newest first — page 15 of 373.
Vertiv Holdings (NYSE:VRT) has completed its acquisition of King Environmental Services (KES), expanding its thermal management services across Europe, the Middle East and Africa.
Eikon Therapeutics (NASDAQ:EIKN) presented updated Phase 2 TeLuRide-005 results showing a 63.1% objective response rate with EIK1001 combined with pembrolizumab and chemotherapy in previously untreated patients with stage 4 non-small cell lung cancer.
Amanat Acquisition (NASDAQ:AMAN) and Corxel US signed a definitive business combination agreement intended to create a publicly traded biopharmaceutical company focused on obesity treatments, with approximately $377 million in potential gross proceeds.
EQT Corporation (NYSE:EQT) announced an agreement to acquire Range Resources (NYSE:RRC) in an all-stock transaction expected to create a natural gas producer with a pro forma enterprise value exceeding $50 billion.
BioNTech (NASDAQ:BNTX) and DualityBio announced that trastuzumab pamirtecan met the primary endpoint of the global Phase 3 DYNASTY-Breast02 trial in patients with HR-positive, HER2-low metastatic breast cancer.
HUTCHMED (NASDAQ:HCM) reported Phase III SANOVO results showing that ORPATHYS plus TAGRISSO reduced the risk of disease progression or death by 44% in previously untreated EGFR-mutated lung cancer patients.
Borr Drilling (NYSE:BORR) said five personnel remained unaccounted for after its Prospector 5 jack-up drilling rig sank offshore Gabon on October 24, 2026.
Phathom Pharmaceuticals (NASDAQ:PHAT) announced that the U.S. Food and Drug Administration established a public docket seeking comments on regulatory questions involving VOQUEZNA's exclusivity protections through May 3, 2032.
Elbit Systems (NASDAQ:ESLT) announced approximately $200 million in contracts to supply airborne intelligence, surveillance, targeting and training solutions to an undisclosed Asia-Pacific country.
Oil prices fell around 2% on Monday, October 26, 2026, as hopes of easing hostilities between the United States and Iran reduced some geopolitical concerns following last week's rally.
HUTCHMED (NASDAQ:HCM) reported positive results from its 338-patient Phase III SAFFRON lung cancer trial, showing that ORPATHYS plus TAGRISSO significantly improved survival compared with platinum-based chemotherapy.
Bristol Myers Squibb (NYSE:BMY) and SystImmune reported positive Phase 3 PANKU-Lung01 results showing that izalontamab brengitecan extended median progression-free survival to 11.1 months in previously treated EGFR-mutated non-small cell lung cancer.
Easterly Government Properties (NYSE:DEA) reported third-quarter 2026 net income of $5.7 million, or $0.12 per diluted share, alongside Core Funds From Operations of $38 million, or $0.78 per diluted share.
Microsoft Corporation (NASDAQ:MSFT) is offering voluntary buyouts to approximately 60,000 employees across four countries, according to a Business Insider report published Monday, October 26, 2026, citing a company spokesperson.
Bristol Myers Squibb (NYSE:BMY) shares fell 2.4% to $61.47 after the company disclosed a fatal septic pneumonia event reported after the data cutoff in an early-stage trial of its experimental multiple sclerosis therapy.
Tango Therapeutics (NASDAQ) reported an 82% objective response rate with vopimetostat plus daraxonrasib in previously treated patients with MTAP-deleted, RAS-mutant pancreatic ductal adenocarcinoma.
Zai Lab (NASDAQ:ZLAB) reported an 81.8% confirmed tumor response rate in a Phase 1b trial of zocilurtatug pelitecan plus atezolizumab for first-line treatment of extensive-stage small cell lung cancer.
GrafTech International (NYSE:EAF) reported third-quarter 2026 net sales of $140 million, down 3% year over year, and a net loss of $47 million, or $1.76 per share.
Rithm Capital Corp. (NYSE:RITM) reported third-quarter 2026 GAAP net income of $217.1 million, or $0.38 per diluted common share, for the quarter ended September 30.
SLB (NYSE:SLB) reported third-quarter 2026 revenue of $9.45 billion, up 6% year over year and 5% sequentially, while net income attributable to the company reached $735 million.
Balchem Corporation (NASDAQ: BCPC) reported third-quarter 2026 net sales of $290.7 million, up 8.6% year over year, as revenue and operating earnings grew across all three reporting segments.
Rogers Communications (NYSE:RCI) reported third-quarter 2026 revenue of C$5.443 billion, up 2% year over year, while adjusted EBITDA increased 1% to C$2.535 billion.
American Express Company (NYSE:AXP) reported third-quarter 2026 net income of $3.7 billion, up from $2.9 billion a year earlier, as earnings per share increased 31% to $5.42.
Booz Allen Hamilton (NYSE:BAH) reported fiscal second-quarter 2027 adjusted earnings of $1.76 per share, exceeding analyst expectations, while revenue reached $2.78 billion.
